mci 154 has been researched along with potassium chloride in 1 studies
| Studies (mci 154) | Trials (mci 154) | Recent Studies (post-2010) (mci 154) | Studies (potassium chloride) | Trials (potassium chloride) | Recent Studies (post-2010) (potassium chloride) |
|---|---|---|---|---|---|
| 65 | 1 | 0 | 18,040 | 395 | 1,764 |
| Protein | Taxonomy | mci 154 (IC50) | potassium chloride (IC50) |
|---|---|---|---|
| Sodium/potassium/calcium exchanger 4 | Homo sapiens (human) | 174000 | |
| Sodium/potassium/calcium exchanger 2 | Homo sapiens (human) | 280000 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Ishisu, R; Nakamura, M; Nakano, T; Onishi, K; Sekioka, K; Tanaka, H; Ueda, Y | 1 |
1 other study(ies) available for mci 154 and potassium chloride
| Article | Year |
|---|---|
MCI-154, a Ca2+ sensitizer, decreases the oxygen cost of contractility in isolated canine hearts.
Topics: Animals; Blood Pressure; Blood Volume; Calcium; Dogs; Energy Metabolism; Heart Arrest, Induced; In Vitro Techniques; Myocardial Contraction; Myocardium; Oxygen Consumption; Potassium Chloride; Pyridazines; Ventricular Function, Left | 1997 |